A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Fever|Hematologic Diseases|Neutropenia|Sepsis
Interventions: DRUG: FLAC chemotherapy with GM-CSF
Sponsor: National Cancer Institute (NCI)